作者：
Zhang,X. [1]
;
Zhao,X. [2]
;
Fiskus,W. [3]
;
Lin,J. [4]
;
Lwin,T. [5]
;
Rao,R. [6]
;
Zhang,Y. [7]
;
Chan,J. [8]
;
Fu,K. [9]
;
Marquez,V. ;
Chen-Kiang,S. ;
Moscinski,L. ;
Seto,E. ;
Dalton,W. ;
Wright,K. ;
Sotomayor,E. ;
Bhalla,K. ;
Tao,J.
作者单位：
Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD
[1]
Department of Pathology, University of Nebraska Medical Center, Omaha, NE 68198, United States
[2]
Immunology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33613, United
[3]
Department of Pathology, Weill-Cornell Medical College, New York, NY 10065, United States
[4]
Department of Malignant Hematology and Experimental Therapeutics Program, H. Lee Moffitt Cancer
[5]
Department of Immunology and Malignant Hematology, Tianjin Cancer Hospital, Tianjin 300060, China
[6]
The Drug Discovery, Delivery and Experimental Therapeutics, University of Kansas Cancer Center
[7]
Dana-Farber Cancer Institute, Boston, MA 02115, United States
[8]
Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33613
[9]
发布时间
2013-11-20
换一批
